WEISS MICHAEL S 4
4 · Checkpoint Therapeutics, Inc. · Filed Dec 17, 2024
Insider Transaction Report
Form 4
WEISS MICHAEL S
Director
Transactions
- Award
COMMON STOCK
2024-12-13+12,638→ 124,812 total(indirect: See Note 3)
Footnotes (3)
- [F1]Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on December 13, 2024.
- [F2]Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board.
- [F3]The shares are held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member.